Anti-Malarial Drugs Market is expected to See Incredible Growth by 2032
In the end of 2021, the global anti-malarial drugs market was estimated to be worth approximately US$ 948.5 million. The market is expected to grow at a 4.8% CAGR and reach a value of US$ 1515.8 million by 2032. Malaria is an infectious disease caused by a female Anopheles mosquito bite, which allows parasites to enter the body. Fever, tiredness, nausea, and headaches are other symptoms caused by merozoites, which also multiply inside red blood cells. Antimalarial medications are those that are used to treat and prevent malaria infections. For the treatment of malarial infection, several medications are available on the market, including quinine, chloroquine, proguanil, mefloquine, and pyrimethamine. The anti-malarial drugs market refers to the pharmaceutical industry segment that produces and sells medications used to prevent and treat malaria, a life-threatening disease caused by parasites transmitted to humans through mosquito bites. The market is driven by the prevalence of malari...